Nucleic Acid Therapeutics CDMO Market, By Type, By Service, By End Use, By Application, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Description

Nucleic Acid Therapeutics CDMO market size was valued at US$ 17,508.3 Million in 2025, expanding at a CAGR of 14.3% from 2026 to 2033.

The nucleic acid drugs represent a family of artificial oligonucleotides (DNA, RNA, or analogs of nucleotide bases) with a well-defined sequence that will be able to bind with the target DNA sequence through Watson-Crick base pairing. The nucleic acid drug structure, which can undergo modifications to its backbone (phosphorothioate bonds) or sugar units (2'-O-methyl or locked nucleic acids), enables the manipulation of the gene expression of the target DNA by antisense binding, RNA interference, or splice modulation. Thus, nucleic acid therapeutics offer highly specific genetic regulation for advanced targeted treatment strategies.

Nucleic Acid Therapeutics CDMO Market- Market Dynamics

Rapid Expansion of RNA-Based Therapeutics to Drive Market Growth

The rise in RNA-based therapeutic drugs is among the main reasons that impact the development of the Nucleic Acid Therapeutics CDMO market owing to growing demands in the development and manufacturing of these RNA-based drugs. For instance, in 2026, according to a comprehensive review published in the U.S. National Library of Medicine (PMC), because of the advancements in mRNAs, siRNAs, ASOs, and RNA editing as described in detail in the review made by the U.S. National Library of Medicine (PMC). Already over 20 RNA-based drugs have been approved worldwide, while others are at different stages of clinical trials; that is, Phase I, II, and III, for treatments of cancer, genetic diseases, infectious diseases, and metabolic diseases. This accelerating clinical progress is significantly increasing demand for specialized CDMO capabilities worldwide.

Nucleic Acid Therapeutics CDMO Market- Segmentation Analysis:

The Global Nucleic Acid Therapeutics CDMO market is segmented on the basis of Type, Service, End Use, Application, and Region.

Among the given applications, infectious diseases account for a prominent share because of the growing need for nucleic acid drugs for viral, bacterial, and novel infections owing to the advances made in the field of RNA- and DNA-based drug manufacturing. In May 2025, Aldevron, which is a part of Danaher, partnered with Integrated DNA Technologies to introduce the first personalized CRISPR therapy using mRNA through advanced manufacturing technologies for DNA and RNA, contributing to the development of next generation nucleic acid medicines for genetic and infectious diseases. This trend is expected to further accelerate innovation and adoption of nucleic acid therapeutics globally.

Nucleic Acid Therapeutics CDMO Market- Geographical Insights

North America dominated the Nucleic Acid Therapeutics CDMO market due to its supportive regulatory environment, increasing investment and funding activities, and a rising number of product approvals. For instance, in 2026, according to the National Academies of Sciences, Engineering, and Medicine's initiative on aligning investments in therapeutic innovation with disease burden and unmet needs, growing attention is being directed toward increasing investment in therapeutics that address high-priority health challenges and underserved patient populations. The study brings together a multidisciplinary committee of 16 experts from healthcare, biopharmaceuticals, and policy to evaluate how research and development funding can be more effectively allocated toward areas with the greatest unmet medical need. This investment momentum is expected to accelerate innovation and strengthen regional market growth.

India Nucleic Acid Therapeutics CDMO market - Country Insights

The India Nucleic Acid Therapeutics CDMO market is expected to see high levels of growth owing to its cost-effective manufacturing infrastructure, high-caliber workforce, and the presence of high-end WHO-cGMP-compliant manufacturing plants. For instance, according to CDSCO Gov, there are 2,006 WHO-cGMP-certified pharmaceutical manufacturing facilities in India spread throughout different states in the list up till now, which means that India is blessed with many top-class WHO-cGMP manufacturing facilities. Gujarat stands first with 684 WHO-cGMP-certified manufacturing plants, followed by Maharashtra with 229, Himachal Pradesh with 202, Telangana with 172, and Uttarakhand with 128 WHO-cGMP manufacturing facilities. This strong manufacturing base positions India as a preferred hub for nucleic acid therapeutics CDMO services.

Nucleic Acid Therapeutics CDMO Market- Competitive Landscape:

Leading companies in the global market, including LGC Limited, Merck KGaA, WuXi AppTec, BIOSPRING, and Univercells Inc., are putting all their efforts into strategic growth. Such companies have been concentrating on collaborations, acquisitions, capacity expansion, and other service launches that could prove beneficial for their market shares, technologies, and worldwide presence. In October 2025, BIOSPRING launched manufacturing services for Luxna Biotech's unique XNA amidite portfolio that includes AmNA(TM), scpBNA(TM), and 5'-CP(TM) chemistries. The launch of this product line will improve the therapeutic oligonucleotide contract development and manufacturing organization services provided by BIOSPRING due to the advanced nucleic acid medicines with improved affinity, increased stability, and lower toxicity. These moves will increase the speed of innovations of companies operating in the global market.

Recent Developments:

In June 2026, Merck KGaA agreed to acquire Bio-Techne Corporation for approximately USD 11.3 billion, significantly expanding its life science business. The acquisition strengthens Merck's portfolio of research reagents, proteins, antibodies, and analytical tools supporting biopharmaceutical and nucleic acid therapeutics development.

In March 2026, Agilent Technologies launched Agilent Advanced Therapeutics, integrating its nucleic acid manufacturing and CDMO capabilities to provide end-to-end oligonucleotide development and production services supporting advanced therapeutic programs, including infectious disease-focused nucleic acid therapies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Agilent Technologies, Inc.
Curia Global, Inc.
Ajinomoto Co., Inc.
Danaher Corporation
Aldevron
Integrated DNA Technologies (IDT)
KNC Laboratories Co., Ltd.
LGC Limited
Axolabs GmbH
Merck KGaA
WuXi AppTec Co., Ltd.
BioSpring GmbH
Univercells Inc.
Exothera SA
AGC Biologics, Inc.
Asymchem Inc.
Bachem AG
BioCina
CMIC HOLDINGS Co., Ltd.
Eurofins Scientific SE
Kaneka Corporation
Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

Plasmid DNA
Antisense Oligonucleotides
siRNA Therapeutics
mRNA Therapeutics
Gene Therapy
Viral Vector-based Products
Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY SERVICE- MARKET ANALYSIS, 2020 - 2033

Process Development and Optimization
Manufacturing Services
Analytical and Quality Control Services
Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033

Pharmaceutical Companies
Biotech Companies
Government & Academic Research Institutes
Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

Genetic Disorders
Infectious Diseases
Oncology
Metabolic Disorders
Rare Diseases
Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

Product Code: ANV6849

1. Nucleic Acid Therapeutics CDMO Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Nucleic Acid Therapeutics CDMO Market Snippet by Type
- 2.1.2. Nucleic Acid Therapeutics CDMO Market Snippet by Service
- 2.1.3. Nucleic Acid Therapeutics CDMO Market Snippet by End Use
- 2.1.4. Nucleic Acid Therapeutics CDMO Market Snippet by Application
- 2.1.5. Nucleic Acid Therapeutics CDMO Market Snippet by Country
- 2.1.6. Nucleic Acid Therapeutics CDMO Market Snippet by Region
2.2. Competitive Insights

3. Nucleic Acid Therapeutics CDMO Key Market Trends

3.1. Nucleic Acid Therapeutics CDMO Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Nucleic Acid Therapeutics CDMO Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Nucleic Acid Therapeutics CDMO Market Opportunities
3.4. Nucleic Acid Therapeutics CDMO Market Future Trends

4. Nucleic Acid Therapeutics CDMO Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Nucleic Acid Therapeutics CDMO Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Nucleic Acid Therapeutics CDMO Market Landscape

6.1. Nucleic Acid Therapeutics CDMO Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Nucleic Acid Therapeutics CDMO Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
- 7.1.2. Plasmid DNA
- 7.1.3. Antisense Oligonucleotides
- 7.1.4. siRNA Therapeutics
- 7.1.5. mRNA Therapeutics
- 7.1.6. Gene Therapy
- 7.1.7. Viral Vector-based Products
- 7.1.8. Others

8. Nucleic Acid Therapeutics CDMO Market - By Service

8.1. Overview
- 8.1.1. Segment Share Analysis, By Service, 2025 & 2033 (%)
- 8.1.2. Process Development and Optimization
- 8.1.3. Manufacturing Services
- 8.1.4. Analytical and Quality Control Services
- 8.1.5. Others

9. Nucleic Acid Therapeutics CDMO Market - By End Use

9.1. Overview
- 9.1.1. Segment Share Analysis, By End Use, 2025 & 2033 (%)
- 9.1.2. Pharmaceutical Companies
- 9.1.3. Biotech Companies
- 9.1.4. Government & Academic Research Institutes
- 9.1.5. Others

10. Nucleic Acid Therapeutics CDMO Market - By Application

10.1. Overview
- 10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 10.1.2. Genetic Disorders
- 10.1.3. Infectious Diseases
- 10.1.4. Oncology
- 10.1.5. Metabolic Disorders
- 10.1.6. Rara Diseases
- 10.1.7. Others

11. Nucleic Acid Therapeutics CDMO Market - By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.17. Denmark
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.17.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.17.4. Denmark Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.17.5. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.17.6. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.18. Rest of Europe
  - 11.3.18.1. Overview
  - 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.18.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.18.4. Rest of the Europe Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.18.5. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.16. Taiwan
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.16.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.16.4. Taiwan Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.16.5. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.16.6. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.17. Vietnam
  - 11.4.17.1. Overview
  - 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.17.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.17.4. Vietnam Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.17.5. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.17.6. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.18. Rest of APAC
  - 11.4.18.1. Overview
  - 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.18.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.18.4. Rest of APAC Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.18.5. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.18.6. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.14. Iran
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.14.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.14.4. Iran Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.6.14.5. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.6.14.6. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.15. Qatar
  - 11.6.15.1. Overview
  - 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.15.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.15.4. Qatar Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.6.15.5. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.6.15.6. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.16. Rest of MEA
  - 11.6.16.1. Overview
  - 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.16.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.16.4. Rest of MEA Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.6.16.5. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.6.16.6. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Nucleic Acid Therapeutics CDMO Industry

12.1. Competitive Benchmarking
- 12.1.1. Competitive Dashboard
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Agilent Technologies, Inc.
- 12.2.2. Curia Global, Inc.
- 12.2.3. Ajinomoto Co., Inc.
- 12.2.4. Danaher Corporation
- 12.2.5. Aldevron
- 12.2.6. Integrated DNA Technologies (IDT)
- 12.2.7. KNC Laboratories Co., Ltd.
- 12.2.8. LGC Limited
- 12.2.9. Axolabs GmbH
- 12.2.10. Merck KGaA
- 12.2.11. WuXi AppTec Co., Ltd.
- 12.2.12. BioSpring GmbH
- 12.2.13. Univercells Inc.
- 12.2.14. Exothera SA
- 12.2.15. AGC Biologics, Inc.
- 12.2.16. Asymchem Inc.
- 12.2.17. Bachem AG
- 12.2.18. BioCina
- 12.2.19. CMIC HOLDINGS Co., Ltd.
- 12.2.20. Eurofins Scientific SE
- 12.2.21. Kaneka Corporation
- 12.2.22. Others

13. 360 Degree AnalystView

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us